期刊文献+

卵巢癌顺铂耐药细胞系的建立 被引量:1

Establishment of a new cisplatin resistant cell line of human ovarian cancer
暂未订购
导出
摘要 目的 :建立人卵巢癌体外耐药模型 ,研究卵巢癌对顺铂的耐药特征。方法 :模仿临床卵巢癌化疗模型 ,采用中等浓度、间歇作用法 ,从人卵巢癌细胞株SKOV3培养出对顺铂耐药细胞系SKOV3/DDP ;倒置显微镜下观察细胞形态 ;MTT法、单克隆形成法检测耐药细胞的耐药指数 ;流式细胞仪检测两种细胞的细胞周期分布。结果 :SKOV3/DDP细胞形态无明显改变 ;耐药指数用MTT法检测为 1 8,单克隆形成法检测为 8;SKOV3主要分布于G0 -G1期 ,SKOV3/DDP主要分布于S期及G2 -M期。结论 :中等剂量、间歇作用法可以诱导出卵巢癌细胞株SKOV3对顺铂耐药性。此项研究结果可为临床卵巢癌化疗方案的制定。 To establish a new cisplatin (DDP)resistant cell line of human ovarian cancer and investigate its features and resistant mechanism to DDP. A DDP resistant human ovarian cancer cell line (SKOV3/DDP)was induced by moderate concentration and intermittent action with DDP. The resistance index was determined by MTT and clonogenic survival test,the cell cycle was detected by flow cytometry (FCM). The RI of SKOV3/DDP was 1 8 by MTT and 8 by clonogenic survival. SKOV3 is mainly in G 0-G 1,but SKOV3/DDP is mainly...
出处 《大连医科大学学报》 CAS 2001年第1期16-18,共3页 Journal of Dalian Medical University
关键词 卵巢肿瘤 顺铂 药物耐受性 细胞系 ovarian cancer cisplatin drug resistance cell line
  • 相关文献

参考文献8

  • 1[1]Ozols RF,Rubin SC,Thomas G,et al.Epithelial ovarian cancer.in:Hoskins WJ,Young RC,et al.Principles and practice of genecologic oncology[J].Philadelphia:Lippncott Raven,1997,919—927.
  • 2[2]Johnson WS,Ozols RF,Hamilton TC.Mechanisms of drug resistance in ovarian cancer[J].Cancer,1993,71:644—649.
  • 3[3]Brent C.Behrens,Thomas C Hamilton,Kidetaka Masuda,et al.Characterization of a cis-Diammine Dichloroplatinum(Ⅱ)resistant human ovarian cancer cell line and its use in evaluation of platinum analoguses[J].J Biol.Chem,1998,267:115—120.
  • 4[4]Sargent JM,Taylor CG.Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leulcemia[J].Br.J.Caneer,1989,60:205—207.
  • 5[5]Grace Bradley,Michael Naik,and Victor Ling.P-glycoprotein expression in multidrug resistant human ovarian carcinoma cell lines[J].Cancer Research,1989,49:2790—2796.
  • 6[6]Laurence M,Levasseur,Harry K.Slocum,et al.Modeling of the time dependency of in vitro drug cytotoxity and resistance[J].Cancer Research,1998,58:5749—5753.
  • 7[7]Joseph P.Eder,Victor T-W.Chan.DNA topoisomerase expression is associated with alkylating agent resistance[J].Cancer Research,1995,55:6109—6116.
  • 8[8]Doward AM,Singh G.Energetic characteristics of cisplatin resistant ovarian carcinoma cells[J].Anticancer Res,1996,16(1):443—447.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部